Market overview
The global immunoassay market is worth USD 43.5 bn in 2026 and is forecast to reach USD 81.6 bn by 2036, growing at a 6.5% CAGR. United States is the largest country market and Reagents and kits is the largest by product segment.
| Scope | Immunoassay tests that detect proteins, hormones, antibodies and infectious markers using antibody binding: chemiluminescence, ELISA, fluorescence and rapid assays, with analyzers and reagents. |
|---|---|
| Industry | Healthcare |
| Value 2025 | USD 41.0 bn |
| Value 2026 | USD 43.5 bn |
| Value 2036 | USD 81.6 bn |
| CAGR 2026-2036 | 6.5% |
| Volume 2026 | 9,446 million tests |
| Volume 2036 | 16,051 million tests |
| Average price 2026 | USD 4.60 per test |
| Report price | Starts from USD 1,999 |
| Published | November 2026 |
Request a free sample of this report
Immunoassay market size and forecast, 2026-2036
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Year | Market value |
|---|---|
| 2026 | USD 43.5 bn |
| 2027 | USD 46.3 bn |
| 2028 | USD 49.3 bn |
| 2029 | USD 52.5 bn |
| 2030 | USD 55.9 bn |
| 2031 | USD 59.5 bn |
| 2032 | USD 63.4 bn |
| 2033 | USD 67.5 bn |
| 2034 | USD 71.9 bn |
| 2035 | USD 76.6 bn |
| 2036 | USD 81.6 bn |
Immunoassay market segmentation
By product
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Reagents and kits | 74.0% | 73.6% | USD 32.2 bn | 6.4% |
| Analyzers | 14.0% | 12.7% | USD 6.1 bn | 5.4% |
| Software and services | 12.0% | 13.7% | USD 5.2 bn | 7.9% |
By technology
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Chemiluminescence | 52.0% | 57.7% | USD 22.6 bn | 7.6% |
| ELISA | 16.0% | 12.2% | USD 7.0 bn | 3.6% |
| Fluorescence | 8.0% | 7.7% | USD 3.5 bn | 6.1% |
| Rapid and lateral flow | 16.0% | 15.4% | USD 7.0 bn | 6.1% |
| Other | 8.0% | 7.0% | USD 3.5 bn | 5.1% |
By application
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Infectious diseases | 26.0% | 23.7% | USD 11.3 bn | 5.5% |
| Endocrinology and fertility | 16.0% | 16.0% | USD 7.0 bn | 6.5% |
| Oncology | 14.0% | 16.1% | USD 6.1 bn | 8.0% |
| Cardiology | 14.0% | 14.0% | USD 6.1 bn | 6.5% |
| Autoimmune and allergy | 10.0% | 11.0% | USD 4.3 bn | 7.5% |
| Other | 20.0% | 19.1% | USD 8.7 bn | 6.0% |
By end user
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Hospitals | 36.0% | 34.0% | USD 15.6 bn | 5.9% |
| Diagnostic laboratories | 34.0% | 33.0% | USD 14.8 bn | 6.2% |
| Pharma and academic | 16.0% | 17.0% | USD 7.0 bn | 7.2% |
| Point of care and home | 14.0% | 16.0% | USD 6.1 bn | 7.9% |
By automation level
| Segment | Share 2026 | Share 2036 | Value 2026 | CAGR 2026-36 |
|---|---|---|---|---|
| Fully automated | 62.0% | 64.0% | USD 26.9 bn | 6.8% |
| Semi-automated | 24.0% | 22.0% | USD 10.4 bn | 5.6% |
| Manual and rapid formats | 14.0% | 14.0% | USD 6.1 bn | 6.5% |
Top 25 countries for immunoassay by revenue
Countries are ranked by revenue earned from sales in the country, not by where the product is made. The ten largest hold 81.5% of 2026 revenue and the 25 countries below together hold 94.8%.
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
| # | Country | Value 2026 | Share 2026 | Value 2036 | CAGR 2026-36 |
|---|---|---|---|---|---|
| 1 | United States | USD 13.5 bn | 31.0% | USD 23.1 bn | 5.5% |
| 2 | China | USD 7.4 bn | 17.0% | USD 17.5 bn | 9.0% |
| 3 | Germany | USD 3.0 bn | 7.0% | USD 5.0 bn | 5.0% |
| 4 | Japan | USD 3.0 bn | 7.0% | USD 4.7 bn | 4.5% |
| 5 | France | USD 1.7 bn | 4.0% | USD 2.9 bn | 5.1% |
| 6 | United Kingdom | USD 1.5 bn | 3.5% | USD 2.6 bn | 5.5% |
| 7 | Italy | USD 1.5 bn | 3.5% | USD 2.4 bn | 4.9% |
| 8 | Brazil | USD 1.3 bn | 3.0% | USD 2.7 bn | 7.5% |
| 9 | India | USD 1.3 bn | 3.0% | USD 3.7 bn | 10.9% |
| 10 | Spain | USD 1.1 bn | 2.5% | USD 1.9 bn | 5.6% |
| 11 | Canada | USD 600 mn | 1.4% | USD 1.1 bn | 5.8% |
| 12 | South Korea | USD 600 mn | 1.4% | USD 1.1 bn | 5.8% |
| 13 | Mexico | USD 526 mn | 1.2% | USD 1.2 bn | 8.1% |
| 14 | Australia | USD 526 mn | 1.2% | USD 922 mn | 5.8% |
| 15 | Russia | USD 452 mn | 1.0% | USD 783 mn | 5.7% |
| 16 | Turkey | USD 452 mn | 1.0% | USD 987 mn | 8.1% |
| 17 | Netherlands | USD 374 mn | 0.9% | USD 653 mn | 5.7% |
| 18 | Switzerland | USD 374 mn | 0.9% | USD 653 mn | 5.7% |
| 19 | Poland | USD 300 mn | 0.7% | USD 522 mn | 5.7% |
| 20 | Taiwan | USD 300 mn | 0.7% | USD 522 mn | 5.7% |
| 21 | Indonesia | USD 300 mn | 0.7% | USD 783 mn | 10.1% |
| 22 | Saudi Arabia | USD 300 mn | 0.7% | USD 653 mn | 8.1% |
| 23 | Thailand | USD 226 mn | 0.5% | USD 489 mn | 8.0% |
| 24 | Iran | USD 226 mn | 0.5% | USD 392 mn | 5.7% |
| 25 | Belgium | USD 226 mn | 0.5% | USD 392 mn | 5.7% |
| Rest of world | USD 2.3 bn | 5.2% | USD 4.1 bn | 6.1% |
Source: Compare Market Research analysis.
© 2026 Compare Market Research. All rights reserved.
Competitive landscape
Group 1: Global leaders
- Roche
- Abbott
- Siemens Healthineers
- Beckman Coulter
- bioMerieux
- QuidelOrtho
- Thermo Fisher Scientific
Group 2: Regional and specialist players
- Bio-Rad Laboratories
- DiaSorin
- Sysmex
- Snibe Diagnostics
- Tosoh
- Fujirebio
- Revvity
- Werfen
- Randox Laboratories
Group 3: Emerging and niche players
- Mindray
- Autobio Diagnostics
- Maccura Biotechnology
- Getein Biotech
- Boditech Med
- Wondfo Biotech
- Hotgen Biotech
Research methodology
Every figure on this page comes from the research framework that we apply to all of the markets we cover. The 2025 base for the immunoassay market is built from the volume sold and the price that buyers pay, and is cross-checked against the size of the wider industry the market belongs to. Where a market can be sized in more than one way, the routes are compared before a figure is set.
The forecast runs year by year from the 2025 base to 2036. Growth in each year reflects demand from the industries that buy the product, adoption of new technology, pricing, regulation and replacement cycles. Volume and price are modelled together, so revenue in each year equals volume multiplied by average price. The 2026 to 2036 compound annual growth rate of 6.5% is calculated from the resulting values.
The market is divided by product, by technology, by application, by end user, by automation level. The 25 largest countries are ranked by revenue earned from sales to buyers in each country, not by where the product is made. Segment values and country values add up to the market total in every year, and every report is checked for consistency before it is published.
Companies are placed in three groups: global leaders, regional and specialist players, and emerging and niche players. The groups describe how companies compete in the market. They are not a ranking and they are not market shares.
Our analysts also carry out primary research. Customized reports add interviews with key opinion leaders, such as senior executives, technical specialists and buyers, to test the assumptions behind the numbers for the question being asked.
Frequently asked questions
How big is the immunoassay market?
The global immunoassay market is estimated at USD 41.0 bn in 2025 and USD 43.5 bn in 2026.
How fast will the immunoassay market grow?
It is forecast to reach USD 81.6 bn by 2036, a compound annual growth rate of 6.5% from 2026, an increase of USD 38.1 bn.
Which country is the largest market for immunoassay?
United States is the largest market by revenue at USD 13.5 bn in 2026, 31.0% of the global total. The three largest countries together hold 55.0%.
Which country is growing fastest?
Among the ten largest markets, India is growing fastest at 10.9% a year from 2026 to 2036.
Which immunoassay segment is largest?
In the by product split, Reagents and kits is the largest segment with 74.0% of 2026 revenue.
Who are the leading immunoassay companies?
Global leaders include Roche, Abbott, Siemens Healthineers, Beckman Coulter.
Need the full report?
Request a sample to see the structure, tables and country detail.
Request a free sampleRelated markets in Healthcare
- Precision MedicineUSD 42.2 bn · 11.0% CAGR
- Point of Care TestingUSD 44.9 bn · 7.0% CAGR
- Electronic Health RecordsUSD 40.9 bn · 7.0% CAGR
- Medical TourismUSD 40.3 bn · 12.0% CAGR
- Inhalation Drug DeliveryUSD 40.1 bn · 5.5% CAGR
- Urgent CareUSD 49.8 bn · 6.3% CAGR
- BiosimilarsUSD 37.8 bn · 15.0% CAGR
- Medical ImagingUSD 50.6 bn · 5.0% CAGR